XML 91 R31.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity |
Schedule of total shares | ​
​ | ​ | ​
Common shares issued and outstanding at December 31, 2020 |  | 180,460,565
Follow-on public offering, incl. Greenshoe | ​ | 5,750,000
Share option exercises | ​ | 910,163
Common shares issued and outstanding at December 31, 2021 | ​ | 187,120,728
Shares issued as part of the at-the-market offering program | ​ | 6,908,493
Shares issued to former shareholders of Frame Pharmaceuticals | ​ | 858,496
Shares issued for LTIP option exercises and RSU deliveries | ​ | 109,374
Common shares issued and outstanding at December 31, 2022 | ​ | 194,997,091
Shares issued as part of the at-the-market offering program | ​ | 1,748,218
Shares issued as part of the public offering | ​ | 27,027,028
Shares issued for LTIP option exercises and RSU releases | ​ | 216,338
Common shares issued and outstanding at December 31, 2023 | ​ | 223,988,675

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of classes of share capital. [Refer: Share capital [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 79 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration